FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Krsnaa Diagnostics IPO.
July 19, 2024 12:26:00 PM
Artiva Biotherapeutics has upsized its IPO to $167 million as the allogeneic natural killer (NK) cell therapy prepares to list on the Nasdaq this morning. | The biotech has knocked its share price ...
Published by : FierceBiotechJuly 5, 2024 10:21:20 AM
Krsnaa operates in the business to government segment with public private partnership (PPP) model, positioned as a high quality affordable diagnostic service provider, said Systematix.
Published by : Business Today on MSNJune 24, 2024 11:44:00 AM
The California-based company announced earlier this month that it planned to use part of its IPO haul to advance the development of its lead asset, an allosteric tyrosine kinase 2 (TYK2 ...
Published by : FierceBiotechJune 24, 2024 3:55:00 PM
Foresite Capital Management, Baker Brothers Life Sciences LP and AyurMaya Capital Management Fund LP are listed as principal shareholders in the Alumis IPO. Why Intel�s stock avoided the ...
Published by : MarketWatchJune 26, 2024 8:33:00 PM
This story has been updated to correct Lineage�s headquarters and number of employees. Lineage Inc. on Wednesday filed for an initial public offering as the largest temperature-controlled ...
Published by : MarketWatchJuly 19, 2024 6:40:00 PM
Rona Therapeutics' Series A+ round was led by LongRiver Investments. Investors include Lilly Asia Ventures, among others. The company is developing RNA silencing drugs for cardiometabolic diseases, ...
Published by : ENDPOINTS NEWSJune 26, 2024 8:21:00 AM
Wall Street's most-chosen consumer brand has navigated its way through 10 stock splits and one stock dividend since its initial public offering (IPO) in 1919. Companies enacting stock splits are ...
Published by : The Motley FoolJuly 12, 2024 4:22:00 PM
Since we launched the Nasdaq IPO Pulse Index at the start of the year, it�s been signaling an upswing in initial public offering (IPO) activity. Now that we are at the midpoint of the year ...
Published by : NasdaqJune 6, 2024 12:54:00 AM
Tempus AI (TEM), a developer of AI-based oncology diagnostic products, has set terms for a proposed $400M initial public offering. In its latest SEC filing, Tempus said it plans to offer 11.1M ...
Published by : MSNJune 26, 2024 6:08:00 PM
Zorzal Inversiones Tecnologicas will become the first company in Uruguay to conduct an initial public offering in almost eight years this week, after authorities eased the rules on small companies ...
Published by : Bloomberg L.P.June 28, 2024 3:30:00 AM
KUALA LUMPUR: The public portion of Johor Plantations Group Bhd�s initial public offering (IPO), comprising 50 million IPO shares, has been oversubscribed by 2.18 times. In a statement ...
Published by : The StarJune 27, 2024 11:39:00 PM
Webtoon Entertainment Inc. shares climbed 9.5% in the online comics company�s debut after a US initial public offering that raised $315 million, priced at the upper end of a marketed range.
Published by : Bloomberg L.P.The IPO Shares of Krsnaa Diagnostics Limited IPO are proposed to list on Monday, August 16, 2021 at BSE, NSE. The public issue of Krsnaa Diagnostics IPO was opened on Aug 4, 2021 and closed for subscription on Aug 6, 2021. Krsnaa Diagnostics IPO Listing Date and Information:
Listing Date | Monday, August 16, 2021 |
BSE Script Code | 543328 |
NSE Symbol | KRSNAA |
Listing In | |
ISIN | INE08LI01020 |
Issue Price | ₹954 Per Equity Share |
Face Value | ₹5 Per Equity Share |
The allotment status of Krsnaa Diagnostics Limited IPO is now available online. The public issue of Krsnaa Diagnostics IPO was open on Aug 4, 2021 and closed for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE
.
The issue of Krsnaa Diagnostics Limited opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 933- Rs 954 Per Equity Share.
Krsnaa Diagnostics Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 5 aggregating up to Rs 1213.33 Crore. The price for the issue has been set at Rs 933- Rs 954 Per Equity Share.
Incorporated in 2010, Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.
The issue opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The Krsnaa Diagnostics IPO is proposed to open on August 4, 2021. The IPO application ends on August 6, 2021.
Retail investors can apply in the retail or non-institutional investor category from August 4, 2021 to August 6, 2021. The Krsnaa Diagnostics IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Krsnaa Diagnostics IPO will open for subscription on August 4, 2021. The public issue will close on August 6, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|